Form 4 Tracker
Claude Nicaise

Director · 3 filings · Latest: Jul 15, 2026

Gain Therapeutics, Inc.
Sarepta Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SRPT
Claude NicaiseDirectorJan 29, 2026
Option Exercise
$13.7110,500$144.0K38,312
SRPT
Nicaise ClaudeMar 12, 2025
Proposed Sale
$99.652,491$248.2K